\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ \\ lab\\:\\ \\ \\ \ \(0\)\
\-\ na\\:\\ 140\\ \\ \\ k\\:\\ 3\\.8\\ \\ \\ cl\\:\\ 100\\ \\ \\ co2\\:\\ 33\\.5\\ \\ \\ bun\\:\\ 13\\ \\ \\ cr\\:\\ 0\\.8\\ \\ \\ glu\\:\\ 85\\ \\ \\ ca\\:\\ 9\\.3\\ \\ \\ tprot\\:\\ 9\\.8\\ \\ \\ alb\\:\\ 4\\.9\\ \\ \\ alkp\\:\\ 97\\ \\ \\ tbili\\:\\ 0\\.5\\ \\ \\ dirbili\\:\\ 0\\.0\\ \\ \\ \\ ast\\:\\ 24\\ \\ \\ alt\\:\\ 40\\ \\ \\ \\ \ \(0\)\
\-\ wbc\\:\\ 3\\.4\\ \\ \\ rbc\\:\\ 5\\.31\\ \\ \\ hb\\:\\ 15\\.2\\ \\ \\ hct\\:\\ 45\\.1\\ \\ \\ plt\\:\\ 186\\ \\ \\ mcv\\:\\ 85\\.0\\ \\ \\ mch\\:\\ 28\\.7\\ \\ \\ mchc\\:\\ 33\\.8\\ \\ \\ rdw\\:\\ 11\\.7\\ \\ \\ mpv\\:\\ 7\\.5\\ \\ \\ absneut\\:\\ 2\\.28\\ x\\ 10x3\\/mm3\\ \\ \\ n\\:\\ 67\\%\\ \\ \\ l\\:\\ 26\\%\\ \\ \\ m\\:\\ 6\\.0\\%\\ \\ \\ e\\:\\ 1\\.0\\%\\ \\ \\ appearance\\:\\ normochromic\\/normocytic\\,\\ few\\ atypical\\ lymphocytes\\.\\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ \\ \\ circulating\\ inhibitor\\ screen\\:\\ none\\ detected\\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ \\ \\ factor\\ viii\\:\\ 21\\.1\\ \\ \ \(0\)\
\-\ \\ \\ hiv\\:\\ positive\\ \\ \ \(0\)\
\-\ \\ \\ hcv\\:\\ positive\ \(0\)\
\-\ \\â\\€\\¢\\ \\ treatment\\ options\\:\ \(0\)\
\-\ \\Â\\»\\ \\ 1\\.\\ \\ orthopaedic\\ surgery\\ referral\ \(0\)\
\-\ \\Â\\»\\ \\ 2\\.\\ \\ conservative\\ treatment\\ with\\ activity\\ restriction\\,\\ monitored\\ nsaid\\/anti\\-inflammatory\\ use\\,\\ therapeutic\\ exercises\\,\\ and\\ clotting\\ factor\\ replacement\\ on\\ demand\\.\ \(0\)\
\-\ \\Â\\»\\ \\ 3\\.\\ \\ intra\\-articular\\ corticosteroid\\ injection\\ for\\ the\\ inflammatory\\ synovitis\\ component\\ of\\ the\\ disorder\\.\ \(0\)\
\-\ \\Â\\»\\ \\ 4\\.\\ \\ synoviorthesis\\/radionuclide\\ synovectomy\\.\\ \\ this\\ procedure\\ entails\\ radiosynovectomy\\ with\\ phosphorus\\ 32\\-sulfer\\ colloid\\ \\(p32\\ or\\ 32p\\)\\.\\ \\ it\\ is\\ a\\ relatively\\ inexpensive\\ outpatient\\ injection\\ procedure\\ that\\ is\\ effective\\ and\\ associated\\ with\\ a\\ very\\ low\\ rate\\ of\\ complications\\.\ \(0\)\
\-\ \\Â\\»\\ \\ 5\\.\\ \\ surgical\\ treatment\\ \\(in\\ conjunction\\ with\\ factor\\ replacement\\ therapy\\)\\:\ \(0\)\
\-\ \\Â\\»\\Â\\»\\ \\ a\\.\\ \\ surgical\\ synovectomy\\ \\(especially\\ useful\\ in\\ young\\ patients\\)\ \(0\)\
\-\ \\Â\\»\\Â\\»\\ \\ b\\.\\ \\ joint\\ debridement\ \(0\)\
\-\ \\Â\\»\\Â\\»\\ \\ c\\.\\ \\ arthrodesis\\ procedures\\ \\(where\\ appropriate\\)\ \(0\)\
\-\ \\Â\\»\\Â\\»\\ \\ d\\.\\ \\ partial\\ or\\ total\\ arthroplasties\\ when\\ indicated\ \(0\)\
\-\ \\â\\€\\¢\\ \\ prognosis\\:\\ \\ \\ patients\\ tend\\ to\\ have\\ progressive\\ degenerative\\ and\\ inflammatory\\ arthritis\\ with\\ eventual\\ destruction\\ and\\ fibrosis\\ of\\ the\\ involved\\ joints\\ leading\\ to\\ deformity\\ and\\ crippling\\.\\ \\ severity\\ may\\ be\\ decreased\\ with\\ surgical\\ and\\ non\\-surgical\\ treatment\\ options\\.\\ \\ it\\ is\\ usually\\ suggested\\ that\\ total\\ arthroplasties\\ should\\ be\\ the\\ last\\ option\\ for\\ treatment\\ due\\ to\\ the\\ limited\\ lifespan\\ of\\ orthopaedic\\ implants\\.\ \(0\)\
\-\ \\â\\€\\¢\\ \\ left\\ elbow\\:\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ abnormal\\ narrowing\\ of\\ the\\ elbow\\ joint\\ at\\ the\\ humeral\\ radial\\ and\\ humeral\\ ulnar\\ articulations\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ sclerosis\\ and\\ bony\\ irregularity\\ along\\ the\\ cortical\\ surfaces\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ broadening\\ of\\ the\\ radial\\ head\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ mild\\ elevation\\ of\\ the\\ posterior\\ fat\\ pad\\ consistent\\ with\\ synovial\\ thickening\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ a\\ supracondylar\\ process\\ is\\ present\\ as\\ an\\ incidental\\ finding\\.\ \(0\)\
\-\ \\â\\€\\¢\\ \\ bilateral\\ ankles\\:\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ osteopenia\\ of\\ the\\ distal\\ talus\\ and\\ distal\\ fibula\\ bilaterally\\ with\\ bony\\ overgrowth\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ extensive\\ degenerative\\ changes\\ at\\ the\\ tibiotalar\\ joint\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ geodes\\ are\\ present\\ in\\ the\\ left\\ distal\\ tibia\\.\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ the\\ degenerative\\ changes\\ appear\\ worse\\ on\\ the\\ right\\ in\\ comparison\\ to\\ the\\ left\ \(0\)\
\-\ \\â\\€\\¢\\ \\ right\\ wrist\\:\ \(0\)\
\-\ \\ \\ \\Â\\»\\ \\ joint\\ space\\ narrowing\\ between\\ the\\ lunate\\ and\\ the\\ capitate\\.\ \(0\)\
\-\ hemophilic\\ polyarthritis\ \(0\)\
\-\ \\â\\€\\¢\\ \\ differential\\ diagnosis\\ based\\ on\\ radiographic\\ findings\\:\ \(0\)\
\-\ \\Â\\»\\ \\ 1\\.\\ \\ hemophilic\\ polyarthritis\ \(0\)\
\-\ \\Â\\»\\ \\ 2\\.\\ \\ rheumatoid\\ arthritis\ \(0\)\
\-\ \\Â\\»\\ \\ 3\\.\\ \\ pigmented\\ villonodular\\ synovitis\ \(0\)\
\-\ \\Â\\»\\ \\ 4\\.\\ \\ osteoarthritis\ \(0\)\
\-\ \\Â\\»\\ \\ 5\\.\\ \\ hemosiderotic\\ synovitis\ \(0\)\
\-\ \\Â\\»\\ \\ 6\\.\\ \\ arthritic\\ changes\\ secondary\\ to\\ a\\ neuromuscular\\ condition\ \(0\)\
\-\ this\\ patient\\ is\\ a\\ 41\\ year\\-old\\ male\\ with\\ a\\ history\\ of\\ hemophilia\\ a\\,\\ hepatitis\\ c\\,\\ and\\ hiv\\.\\ \\ the\\ patient\\ also\\ has\\ a\\ history\\ of\\ chronic\\ left\\ elbow\\ and\\ bilateral\\ ankle\\ pain\\.\\ \\ he\\ is\\ considering\\ applying\\ for\\ disability\\ and\\ requested\\ radiographic\\ evaluation\\.\\ \\ he\\ is\\ on\\ infusion\\ prophylaxis\\ with\\ refacto\\ q\\.o\\.d\\.\\ \\ he\\ is\\ a\\ manager\\ for\\ numerous\\ christian\\ radio\\ stations\\ and\\ has\\ taken\\ on\\ part\\-time\\ pastor\\ duties\\ at\\ his\\ church\\.\ \(0\)\
\-\ see\\ topic\\ discussion\\.\ \(2\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.21725996245796048\ \(0\)\
\-\ \\:\\:\\ 0\\.08648010157935694\ \(0\)\
\-\ arthroplasties\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ hemophilic\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ synovitis\\:\\ 0\\.028079201223187283\ \(0\)\
\-\ polyarthritis\\:\\ 0\\.027462299413873268\ \(0\)\
\-\ synovectomy\\:\\ 0\\.026438519796607142\ \(0\)\
\-\ elbow\\:\\ 0\\.023534515178125864\ \(0\)\
\-\ factor\\:\\ 0\\.023280272923734822\ \(0\)\
\-\ degenerative\\:\\ 0\\.020679053388027727\ \(0\)\
\-\ orthopaedic\\:\\ 0\\.02053735226421023\ \(0\)\
\-\ joint\\:\\ 0\\.01966853562307531\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.01951797235083846\ \(0\)\
\-\ hiv\\:\\ 0\\.016861142277796365\ \(0\)\
\-\ humeral\\:\\ 0\\.016103412750242373\ \(0\)\
\-\ 33\\.5\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ dirbili\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 5\\.31\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 45\\.1\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 85\\.0\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ absneut\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 10x3\\/mm3\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 21\\.1\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ nsaid\\/anti\\-inflammatory\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ synoviorthesis\\/radionuclide\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ radiosynovectomy\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 32\\-sulfer\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ p32\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ 32p\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ geodes\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ hemosiderotic\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ refacto\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ q\\.o\\.d\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ stations\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ pastor\\:\\ 0\\.015685975843356757\ \(0\)\
\-\ treatment\\:\\ 0\\.015388051242000775\ \(0\)\
\-\ replacement\\:\\ 0\\.014843870195107208\ \(0\)\
\-\ options\\:\\ 0\\.014776083024392993\ \(0\)\
\-\ tprot\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ alkp\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ 28\\.7\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ 33\\.8\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ 2\\.28\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ normochromic\\/normocytic\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ demand\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ crippling\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ part\\-time\\:\\ 0\\.014452617870830164\ \(0\)\
\-\ injection\\:\\ 0\\.014189340521936645\ \(0\)\
\-\ \\%\\:\\ 0\\.014187338315629947\ \(0\)\
\-\ radial\\:\\ 0\\.013941916811443368\ \(0\)\
\-\ hcv\\:\\ 0\\.013731149706936634\ \(0\)\
\-\ entails\\:\\ 0\\.013731149706936634\ \(0\)\
\-\ lifespan\\:\\ 0\\.013731149706936634\ \(0\)\
\-\ broadening\\:\\ 0\\.013731149706936634\ \(0\)\
\-\ christian\\:\\ 0\\.013731149706936634\ \(0\)\
\-\ 0\\.0\\:\\ 0\\.013219259898303571\ \(0\)\
\-\ 15\\.2\\:\\ 0\\.013219259898303571\ \(0\)\
\-\ 186\\:\\ 0\\.013219259898303571\ \(0\)\
\-\ 11\\.7\\:\\ 0\\.013219259898303571\ \(0\)\
\-\ inexpensive\\:\\ 0\\.013219259898303571\ \(0\)\
\-\ church\\:\\ 0\\.013219259898303571\ \(0\)\
\-\ 5\\.\\:\\ 0\\.013116084373820017\ \(0\)\
\-\ total\\:\\ 0\\.013095088921410094\ \(0\)\
\-\ changes\\:\\ 0\\.013073209837553704\ \(0\)\
\-\ arthritis\\:\\ 0\\.012991930427199231\ \(0\)\
\-\ applying\\:\\ 0\\.012822207315893945\ \(0\)\
\-\ procedure\\:\\ 0\\.012736926907959249\ \(0\)\
\-\ he\\:\\ 0\\.012726978694126439\ \(0\)\
\-\ 9\\.3\\:\\ 0\\.012497791734410041\ \(0\)\
\-\ mpv\\:\\ 0\\.012497791734410041\ \(0\)\
\-\ articulations\\:\\ 0\\.012497791734410041\ \(0\)\
\-\ tibiotalar\\:\\ 0\\.012497791734410041\ \(0\)\
\-\ duties\\:\\ 0\\.012497791734410041\ \(0\)\
\-\ distal\\:\\ 0\\.012401843001491247\ \(0\)\
\-\ glu\\:\\ 0\\.01222350226852524\ \(0\)\
\-\ hb\\:\\ 0\\.01222350226852524\ \(0\)\
\-\ 6\\.0\\:\\ 0\\.01222350226852524\ \(0\)\
\-\ circulating\\:\\ 0\\.01222350226852524\ \(0\)\
\-\ arthrodesis\\:\\ 0\\.01222350226852524\ \(0\)\
\-\ radio\\:\\ 0\\.01222350226852524\ \(0\)\
\-\ narrowing\\:\\ 0\\.012193760477402124\ \(0\)\
\-\ bony\\:\\ 0\\.012161408264942154\ \(0\)\
\-\ overgrowth\\:\\ 0\\.011985901925776978\ \(0\)\
\-\ neuromuscular\\:\\ 0\\.011985901925776978\ \(0\)\
\-\ 4\\.\\:\\ 0\\.011973238328828462\ \(0\)\
\-\ 9\\.8\\:\\ 0\\.011776323570516509\ \(0\)\
\-\ mch\\:\\ 0\\.011776323570516509\ \(0\)\
\-\ mchc\\:\\ 0\\.011776323570516509\ \(0\)\
\-\ manager\\:\\ 0\\.011776323570516509\ \(0\)\
\-\ 3\\.8\\:\\ 0\\.011588849343367352\ \(0\)\
\-\ 4\\.9\\:\\ 0\\.011588849343367352\ \(0\)\
\-\ 7\\.5\\:\\ 0\\.011588849343367352\ \(0\)\
\-\ viii\\:\\ 0\\.011588849343367352\ \(0\)\
\-\ hemophilia\\:\\ 0\\.011588849343367352\ \(0\)\
\-\ radiographic\\:\\ 0\\.01154222203483535\ \(0\)\
\-\ phosphorus\\:\\ 0\\.01141925827609987\ \(0\)\
\-\ alb\\:\\ 0\\.011264433761883448\ \(0\)\
\-\ rdw\\:\\ 0\\.011122009015133383\ \(0\)\
\-\ clotting\\:\\ 0\\.011122009015133383\ \(0\)\
\-\ arthritic\\:\\ 0\\.011122009015133383\ \(0\)\
\-\ inhibitor\\:\\ 0\\.010867381179473822\ \(0\)\
\-\ capitate\\:\\ 0\\.010867381179473822\ \(0\)\
\-\ 140\\:\\ 0\\.010752543953250385\ \(0\)\
\-\ non\\-surgical\\:\\ 0\\.010752543953250385\ \(0\)\
\-\ 97\\:\\ 0\\.010644670960694451\ \(0\)\
\-\ eventual\\:\\ 0\\.010644670960694451\ \(0\)\
\-\ inflammatory\\:\\ 0\\.01054560834232037\ \(0\)\
\-\ supracondylar\\:\\ 0\\.010542965597989918\ \(0\)\
\-\ villonodular\\:\\ 0\\.010542965597989918\ \(0\)\
\-\ 3\\.\\:\\ 0\\.01040524630655063\ \(0\)\
\-\ conjunction\\:\\ 0\\.010355491370840759\ \(0\)\
\-\ ankles\\:\\ 0\\.010355491370840759\ \(0\)\
\-\ cl\\:\\ 0\\.010268676132105114\ \(0\)\
\-\ tbili\\:\\ 0\\.010268676132105114\ \(0\)\
\-\ mcv\\:\\ 0\\.010268676132105114\ \(0\)\
\-\ restriction\\:\\ 0\\.010268676132105114\ \(0\)\
\-\ implants\\:\\ 0\\.010268676132105114\ \(0\)\
\-\ 0\\.8\\:\\ 0\\.010185900303573277\ \(0\)\
\-\ 3\\.4\\:\\ 0\\.010185900303573277\ \(0\)\
\-\ infusion\\:\\ 0\\.009958438788431133\ \(0\)\
\-\ surfaces\\:\\ 0\\.00988865104260679\ \(0\)\
\-\ positive\\:\\ 0\\.009867920250121412\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.009821497434096386\ \(0\)\
\-\ co2\\:\\ 0\\.009756786323472053\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.009756786323472053\ \(0\)\
\-\ plt\\:\\ 0\\.009694346252633494\ \(0\)\
\-\ talus\\:\\ 0\\.009694346252633494\ \(0\)\
\-\ pigmented\\:\\ 0\\.009694346252633494\ \(0\)\
\-\ 2\\.\\:\\ 0\\.009670619721709104\ \(0\)\
\-\ surgical\\:\\ 0\\.009588372439064699\ \(0\)\
\-\ intra\\-articular\\:\\ 0\\.009519185980723792\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.009519185980723792\ \(0\)\
\-\ 1\\.\\:\\ 0\\.009498893830240572\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.009464432139679747\ \(0\)\
\-\ exercises\\:\\ 0\\.009464432139679747\ \(0\)\
\-\ disability\\:\\ 0\\.009464432139679747\ \(0\)\
\-\ 0\\.5\\:\\ 0\\.009411312988167858\ \(0\)\
\-\ debridement\\:\\ 0\\.009411312988167858\ \(0\)\
\-\ pad\\:\\ 0\\.009260855002352799\ \(0\)\
\-\ lunate\\:\\ 0\\.009260855002352799\ \(0\)\
\-\ considering\\:\\ 0\\.009260855002352799\ \(0\)\
\-\ monitored\\:\\ 0\\.00916718287871326\ \(0\)\
\-\ cr\\:\\ 0\\.009122133398314166\ \(0\)\
\-\ 67\\:\\ 0\\.009122133398314166\ \(0\)\
\-\ e\\:\\ 0\\.009035318159578521\ \(0\)\
\-\ b\\.\\:\\ 0\\.009035318159578521\ \(0\)\
\-\ d\\.\\:\\ 0\\.009035318159578521\ \(0\)\
\-\ colloid\\:\\ 0\\.008952542331046684\ \(0\)\
\-\ requested\\:\\ 0\\.008873446668109257\ \(0\)\
\-\ n\\:\\ 0\\.00883517939903281\ \(0\)\
\-\ screen\\:\\ 0\\.00883517939903281\ \(0\)\
\-\ osteopenia\\:\\ 0\\.00883517939903281\ \(0\)\
\-\ fibula\\:\\ 0\\.00883517939903281\ \(0\)\
\-\ c\\.\\:\\ 0\\.008797717816830261\ \(0\)\
\-\ rbc\\:\\ 0\\.008761028693693721\ \(0\)\
\-\ synovial\\:\\ 0\\.00872508081590454\ \(0\)\
\-\ hepatitis\\:\\ 0\\.00872508081590454\ \(0\)\
\-\ outpatient\\:\\ 0\\.008655293070080197\ \(0\)\
\-\ effective\\:\\ 0\\.008655293070080197\ \(0\)\
\-\ referral\\:\\ 0\\.00862139948472309\ \(0\)\
\-\ tend\\:\\ 0\\.00862139948472309\ \(0\)\
\-\ therapeutic\\:\\ 0\\.008555489748637058\ \(0\)\
\-\ a\\.\\:\\ 0\\.00852342835094546\ \(0\)\
\-\ 85\\:\\ 0\\.00849193444151592\ \(0\)\
\-\ option\\:\\ 0\\.00849193444151592\ \(0\)\
\-\ bun\\:\\ 0\\.008400665234420636\ \(0\)\
\-\ k\\:\\ 0\\.008285828008197198\ \(0\)\
\-\ ast\\:\\ 0\\.00825824048767057\ \(0\)\
\-\ alt\\:\\ 0\\.00825824048767057\ \(0\)\
\-\ hct\\:\\ 0\\.00825824048767057\ \(0\)\
\-\ severity\\:\\ 0\\.00825824048767057\ \(0\)\
\-\ procedures\\:\\ 0\\.008231074167153154\ \(0\)\
\-\ na\\:\\ 0\\.008204316378248278\ \(0\)\
\-\ irregularity\\:\\ 0\\.008126375768535834\ \(0\)\
\-\ 41\\:\\ 0\\.008101136204493207\ \(0\)\
\-\ topic\\:\\ 0\\.008076249652936731\ \(0\)\
\-\ detected\\:\\ 0\\.008027497029826205\ \(0\)\
\-\ is\\:\\ 0\\.00800413919408862\ \(0\)\
\-\ ulnar\\:\\ 0\\.008003612652011011\ \(0\)\
\-\ useful\\:\\ 0\\.007933824906186666\ \(0\)\
\-\ comparison\\:\\ 0\\.007911157600532877\ \(0\)\
\-\ patients\\:\\ 0\\.007870372239736747\ \(0\)\
\-\ m\\:\\ 0\\.00784483839270862\ \(0\)\
\-\ suggested\\:\\ 0\\.007739520116213371\ \(0\)\
\-\ 100\\:\\ 0\\.0076791970705271054\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.007545920721464618\ \(0\)\
\-\ destruction\\:\\ 0\\.007509606003259624\ \(0\)\
\-\ elevation\\:\\ 0\\.007509606003259624\ \(0\)\
\-\ lab\\:\\ 0\\.007439127109852068\ \(0\)\
\-\ 6\\.\\:\\ 0\\.007388041512196497\ \(0\)\
\-\ bilateral\\:\\ 0\\.007380134268022932\ \(0\)\
\-\ leading\\:\\ 0\\.007274253746003838\ \(0\)\
\-\ ankle\\:\\ 0\\.007243036113173039\ \(0\)\
\-\ c\\:\\ 0\\.007227630307580309\ \(0\)\
\-\ prognosis\\:\\ 0\\.007212356742293135\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.007182197385862933\ \(0\)\
\-\ appropriate\\:\\ 0\\.007167307261894043\ \(0\)\
\-\ discussion\\:\\ 0\\.00712337022881509\ \(0\)\
\-\ ca\\:\\ 0\\.007080492023158399\ \(0\)\
\-\ 26\\:\\ 0\\.007038622810684743\ \(0\)\
\-\ wrist\\:\\ 0\\.0070248825151439775\ \(0\)\
\-\ tibia\\:\\ 0\\.0069842870031045275\ \(0\)\
\-\ joints\\:\\ 0\\.006957728906633574\ \(0\)\
\-\ component\\:\\ 0\\.006944597043114673\ \(0\)\
\-\ l\\:\\ 0\\.006931561384587852\ \(0\)\
\-\ present\\:\\ 0\\.006868358554917013\ \(0\)\
\-\ 13\\:\\ 0\\.006867778231966614\ \(0\)\
\-\ few\\:\\ 0\\.006842891680410137\ \(0\)\
\-\ it\\:\\ 0\\.006835759375562337\ \(0\)\
\-\ disorder\\:\\ 0\\.006830577725170682\ \(0\)\
\-\ numerous\\:\\ 0\\.006818348402594594\ \(0\)\
\-\ left\\:\\ 0\\.006805019710127507\ \(0\)\
\-\ fibrosis\\:\\ 0\\.0067702546794844165\ \(0\)\
\-\ worse\\:\\ 0\\.006735018687854204\ \(0\)\
\-\ young\\:\\ 0\\.006622363386405224\ \(0\)\
\-\ atypical\\:\\ 0\\.006589912163007037\ \(0\)\
\-\ indicated\\:\\ 0\\.006579225287455059\ \(0\)\
\-\ deformity\\:\\ 0\\.006547544460705047\ \(0\)\
\-\ relatively\\:\\ 0\\.006506162143686778\ \(0\)\
\-\ last\\:\\ 0\\.006495965213599616\ \(0\)\
\-\ on\\:\\ 0\\.006440311497913062\ \(0\)\
\-\ limited\\:\\ 0\\.006416427528692308\ \(0\)\
\-\ 40\\:\\ 0\\.006397086474889988\ \(0\)\
\-\ involved\\:\\ 0\\.006377953393437564\ \(0\)\
\-\ condition\\:\\ 0\\.006359023859264868\ \(0\)\
\-\ a\\:\\ 0\\.006351242377877956\ \(0\)\
\-\ taken\\:\\ 0\\.006340293587046029\ \(0\)\
\-\ especially\\:\\ 0\\.006258364870851355\ \(0\)\
\-\ appear\\:\\ 0\\.006223128879221142\ \(0\)\
\-\ where\\:\\ 0\\.006205769137325475\ \(0\)\
\-\ at\\:\\ 0\\.00618023035319377\ \(0\)\
\-\ partial\\:\\ 0\\.006080704132471077\ \(0\)\
\-\ extensive\\:\\ 0\\.006080704132471077\ \(0\)\
\-\ conservative\\:\\ 0\\.006072670893406082\ \(0\)\
\-\ complications\\:\\ 0\\.006025218496462735\ \(0\)\
\-\ use\\:\\ 0\\.006009678140646446\ \(0\)\
\-\ progressive\\:\\ 0\\.006009678140646446\ \(0\)\
\-\ rate\\:\\ 0\\.005926550694796874\ \(0\)\
\-\ 24\\:\\ 0\\.0059118451612561376\ \(0\)\
\-\ process\\:\\ 0\\.005854209047748602\ \(0\)\
\-\ based\\:\\ 0\\.005798381427521281\ \(0\)\
\-\ incidental\\:\\ 0\\.005757630957260277\ \(0\)\
\-\ has\\:\\ 0\\.00571067605158106\ \(0\)\
\-\ activity\\:\\ 0\\.005704709303881741\ \(0\)\
\-\ year\\-old\\:\\ 0\\.005584990430068001\ \(0\)\
\-\ wbc\\:\\ 0\\.005542837812412477\ \(0\)\
\-\ cortical\\:\\ 0\\.005542837812412477\ \(0\)\
\-\ very\\:\\ 0\\.005519191491916599\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0054614150060966985\ \(0\)\
\-\ that\\:\\ 0\\.005252600457504709\ \(0\)\
\-\ for\\:\\ 0\\.005189381840873417\ \(0\)\
\-\ thickening\\:\\ 0\\.005154136245005964\ \(0\)\
\-\ \\(\\:\\ 0\\.005141364599600431\ \(0\)\
\-\ \\)\\:\\ 0\\.0050785600862156945\ \(0\)\
\-\ space\\:\\ 0\\.0050294608666844026\ \(0\)\
\-\ along\\:\\ 0\\.005025006898324761\ \(0\)\
\-\ x\\:\\ 0\\.005016132269301561\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004994137435095913\ \(0\)\
\-\ finding\\:\\ 0\\.0049004653114563725\ \(0\)\
\-\ should\\:\\ 0\\.004847346159944484\ \(0\)\
\-\ differential\\:\\ 0\\.004827330657211618\ \(0\)\
\-\ between\\:\\ 0\\.004819387075132106\ \(0\)\
\-\ be\\:\\ 0\\.004689525705850281\ \(0\)\
\-\ the\\:\\ 0\\.004673908201724004\ \(0\)\
\-\ fat\\:\\ 0\\.004624399151034934\ \(0\)\
\-\ usually\\:\\ 0\\.004617310060261137\ \(0\)\
\-\ see\\:\\ 0\\.004537753044891082\ \(0\)\
\-\ decreased\\:\\ 0\\.004520918866057935\ \(0\)\
\-\ and\\:\\ 0\\.004484210107208289\ \(0\)\
\-\ evaluation\\:\\ 0\\.004416795010367985\ \(0\)\
\-\ his\\:\\ 0\\.0043823648178771026\ \(0\)\
\-\ when\\:\\ 0\\.004354681917466202\ \(0\)\
\-\ appearance\\:\\ 0\\.004348588214830322\ \(0\)\
\-\ abnormal\\:\\ 0\\.004336463061058561\ \(0\)\
\-\ head\\:\\ 0\\.004312457847996256\ \(0\)\
\-\ chronic\\:\\ 0\\.004282899702681494\ \(0\)\
\-\ secondary\\:\\ 0\\.004250943000905351\ \(0\)\
\-\ low\\:\\ 0\\.004228057033570105\ \(0\)\
\-\ history\\:\\ 0\\.004200051735612396\ \(0\)\
\-\ therapy\\:\\ 0\\.00406519714633561\ \(0\)\
\-\ due\\:\\ 0\\.0040574326564997145\ \(0\)\
\-\ mild\\:\\ 0\\.004004009704503802\ \(0\)\
\-\ to\\:\\ 0\\.0037995383313432947\ \(0\)\
\-\ none\\:\\ 0\\.0037717428948541042\ \(0\)\
\-\ consistent\\:\\ 0\\.0037282887345750945\ \(0\)\
\-\ surgery\\:\\ 0\\.0036921691536659696\ \(0\)\
\-\ associated\\:\\ 0\\.003588011675992352\ \(0\)\
\-\ or\\:\\ 0\\.0035641378966679983\ \(0\)\
\-\ posterior\\:\\ 0\\.003504694926516812\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003491493471139537\ \(0\)\
\-\ this\\:\\ 0\\.00342041712923179\ \(0\)\
\-\ may\\:\\ 0\\.0033351038592493304\ \(0\)\
\-\ have\\:\\ 0\\.003292594445489487\ \(0\)\
\-\ findings\\:\\ 0\\.003236364654430533\ \(0\)\
\-\ right\\:\\ 0\\.0032086537690762156\ \(0\)\
\-\ patient\\:\\ 0\\.0030483698609124125\ \(0\)\
\-\ in\\:\\ 0\\.0029992685419235224\ \(0\)\
\-\ also\\:\\ 0\\.0029975437609789167\ \(0\)\
\-\ \\,\\:\\ 0\\.0028901430482272676\ \(0\)\
\-\ male\\:\\ 0\\.0027494760460631193\ \(0\)\
\-\ as\\:\\ 0\\.0022999599749005833\ \(0\)\
\-\ an\\:\\ 0\\.0021026065200795904\ \(0\)\
\-\ with\\:\\ 0\\.002081924841457113\ \(0\)\
\-\ of\\:\\ 0\\.0020730213665122498\ \(0\)\
\-\ are\\:\\ 0\\.0020727293105508924\ \(0\)\
\-\ pain\\:\\ 0\\.0018569540347521968\ \(0\)\
\-\ \\.\\:\\ 0\\.001515994424085962\ \(0\)\
